Antitumour Activity of Organotin Derivatives
Author Information
Author(s): Marcel Gielen, Frangois Kayser, Olga B. Zhidkova, Vladimir Ts. Kampel, Vladimir I. Bregadze, Dick de Vos, Monique Biesemans, Bernard Mahieu, Rudolph Willem
Primary Institution: Free University of Brussels, VUB
Hypothesis
Can organotin derivatives of dicarba-closo-dodecaboranes exhibit selective antitumour activity against human cancer cell lines?
Conclusion
The organotin derivatives demonstrated significant in vitro antitumour activity, particularly against the MCF-7 cancer cell line.
Supporting Evidence
- Compounds 1 and 2 showed high in vitro antitumour activity against the MCF-7 line, comparable to doxorubicin.
- Compound 2 was active in vivo against L1210 murine leukemia at doses of 7 and 10 mg/kg.
- Bis(metacarboranyl)tin dichloride exhibited even higher activities in both MCF-7 and WiDr cell lines.
Takeaway
Scientists created new compounds from boron and tin to see if they could help fight cancer. They found some that worked really well in tests.
Methodology
The study involved synthesizing organotin derivatives and testing their antitumour activities in vitro against various human cancer cell lines using the sulforhodamine B test.
Limitations
The study primarily focused on in vitro results, and in vivo results were limited to one compound and specific conditions.
Want to read the original?
Access the complete publication on the publisher's website